Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans

NCT01681693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Healthy
Type 2 Diabetes Mellitus

Interventions

DRUG: Metformin

Sponsor

University of California, San Francisco